
   <?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Sat, 31 Oct 2026 14:49:07 -0400--><rss version="2.0">
    <channel>
        <title>Processa Pharmaceuticals, Inc. (PCSA) SEC Filings</title>
        <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/rss</link>
        <description>Processa Pharmaceuticals, Inc. (PCSA) - All SEC Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/processapharmaceuticals/files/theme/images/logo-sm.png</url>
                <title>Processa Pharmaceuticals, Inc. Logo</title>
                <link>/investors</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[2 Related Documents: 8-K, EX-99.1]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001140361-26-041116/0001140361-26-041116.pdf</link>
                <pubDate>Thu, 29 Oct 26 08:47:03 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001140361-26-041116/0001140361-26-041116.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[EFFECT - Notice of Effectiveness]]></title>
                <description><![CDATA[EFFECT]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/9999999995-26-003335/9999999995-26-003335.pdf</link>
                <pubDate>Mon, 26 Oct 26 06:01:51 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/9999999995-26-003335/9999999995-26-003335.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DEF 14A - Definitive proxy statements]]></title>
                <description><![CDATA[DEF 14A]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001140361-26-040520/0001140361-26-040520.pdf</link>
                <pubDate>Thu, 22 Oct 26 16:38:27 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001140361-26-040520/0001140361-26-040520.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[PRE 14A - Preliminary proxy statement not related to a contested matter or merger/acquisition]]></title>
                <description><![CDATA[PRE 14A]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001140361-26-039268/0001140361-26-039268.pdf</link>
                <pubDate>Fri, 09 Oct 26 16:55:40 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001140361-26-039268/0001140361-26-039268.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[PRE 14A - Preliminary proxy statement not related to a contested matter or merger/acquisition]]></title>
                <description><![CDATA[PRE 14A]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001140361-26-039267/0001140361-26-039267.pdf</link>
                <pubDate>Fri, 09 Oct 26 16:04:13 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001140361-26-039267/0001140361-26-039267.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[S-3 - Registration statement under Securities Act of 1933]]></title>
                <description><![CDATA[5 Related Documents: S-3, EX-5.1, EX-23.1, EX-23.2, EX-FILING FEES]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001140361-26-039266/0001140361-26-039266.pdf</link>
                <pubDate>Fri, 09 Oct 26 16:02:45 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001140361-26-039266/0001140361-26-039266.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K/A - Current report]]></title>
                <description><![CDATA[7 Related Documents: 8-K/A, EX-23.1, EX-99.3, EX-99.4, EX-99.5, EX-99.6, EX-99.7]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001140361-26-038535/0001140361-26-038535.pdf</link>
                <pubDate>Mon, 05 Oct 26 07:21:47 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001140361-26-038535/0001140361-26-038535.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors]]></title>
                <description><![CDATA[2 Related Documents: SCHEDULE 13G, EX-99.A]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001213900-26-091285/0001213900-26-091285.pdf</link>
                <pubDate>Tue, 18 Aug 26 17:00:27 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001213900-26-091285/0001213900-26-091285.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-10.1, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-26-038334/0001493152-26-038334.pdf</link>
                <pubDate>Fri, 14 Aug 26 16:22:57 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-26-038334/0001493152-26-038334.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0000897069-26-001602/0000897069-26-001602.pdf</link>
                <pubDate>Tue, 11 Aug 26 16:26:02 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0000897069-26-001602/0000897069-26-001602.pdf</guid>
                                                                            </item>
            </channel>
</rss>